Unexplained weight loss (UWL), clinically defined as a loss of 5% or more of body weight within a six to twelve-month period, is a challenging diagnostic puzzle. It often indicates serious underlying pathology and necessitates a thorough and systematic approach for accurate diagnosis.
UWL can be attributed to a myriad of causes, most commonly malignancies, gastrointestinal disorders, endocrine diseases, and psychiatric illnesses. Understanding the pathophysiology of these conditions is crucial in formulating a comprehensive diagnostic plan.
A patient-centric, systematic approach is recommended for diagnosing UWL. A detailed history, physical examination, and basic laboratory tests form the cornerstone of this approach. Special attention should be given to age, associated symptoms, and risk factors. In older patients, malignancies and chronic diseases are more prevalent, while in younger patients, psychiatric disorders and malabsorption syndromes should be considered.
While routine imaging is not recommended, it may be warranted in certain cases. For instance, if the clinical history and physical examination suggest a specific organ involvement, targeted imaging can be beneficial. Similarly, in patients with significant weight loss and no clear diagnosis after initial evaluation, computed tomography (CT) of the chest, abdomen, and pelvis may be considered.
Follow-up is crucial in cases of UWL. If initial investigations are inconclusive, patients should be closely monitored for the emergence of new symptoms. This allows for timely intervention and improved patient outcomes.
Diagnosing UWL requires a comprehensive, systematic, and patient-centric approach. Understanding the etiology, adopting an appropriate diagnostic approach, recognizing the role of imaging, and emphasizing the importance of follow-up are all integral to successfully deciphering this enigma. By doing so, clinicians can ensure timely and appropriate management, ultimately improving patient outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation